Author

Mia Bendix 1

1 Aarhus University Hospital,Aarhus,Denmark

CLINICAL TRIAL: HIGH-DOSE VITAMIN D TREATMENT TO CROHN'S DISEASE PATIENTS WITH DISEASE ACTIVITY, A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLINDED STUDY (MIRVIDIC)

Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bent Deleuran, Jørgen Agnholt

CLINICAL TRIAL: HIGH-DOSE VITAMIN D TREATMENT TO CROHN’S DISEASE PATIENTS WITH DISEASE ACTIVITY, A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLINDED STUDY (MIRVIDIC).

Mia Bendix

DIETARY INTERVENTION WITH A DIET RICH IN ARABINOXYLANS AND RESISTANT STARCH MODULATES T-CELL ACTIVATION ESTIMATED BY CD25 EXPRESSION IN METABOLIC SYNDROME

Stine Hald, Anders Kirch Dige, Sidsel Stoy, Mia Bendix, Anne Grethe Schioldan, Kjeld Hermansen, Søren Gregersen, Knud Erik Bach Knudsen, Jørgen Agnholt, Jens Frederik Dahlerup, Anders Dige

RANDOMISED CLINICAL TRIAL: CASEIN GLYCOMACROPEPTIDE FOR ACTIVE DISTAL ULCERATIVE COLITIS – A PILOT STUDY

Pernille Glahn Wernlund, Christian Lodberg Hvas, Anders Kirch Dige, Mia Bendix, Lisbet Ambrosius Christensen, Jens Frederik Dahlerup, Jørgen Agnholt

Seven weeks high-dose vitamin D treatment in Crohn's disease reduces the need for intensified infliximab treatment during 52 weeks follow up

Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, Jørgen Agnholt

SEVEN WEEKS HIGH-DOSE VITAMIN D TREATMENT IN CROHN'S DISEASE REDUCES THE NEED FOR INTENSIFIED INFLIXIMAB TREATMENT DURING 52 WEEKS FOLLOW UP

Mia Bendix

Item 1 - 6 / 10
1